Dascena, Inc.
Machine learning software that learns from clinician decisions in electronic health records to autonomously label and predict sepsis cases, reducing false alerts in clinical decision support systems
- Sector
- Digital health
- Headquarters
- Hayward, CA
- Total capital
- $4.9M
- Federal grants
- $4.7M
- 10 awards · 2015–2021
- Rank in peer group#12 of 32
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $172K
- 1 award · Health and Human S
- Rank in Digital health#30 of 818
- Granted patents
- 0
- 13 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Using Clinical Treatment Data in a Machine Learning Approach for Sepsis Detection$2M
- Federal grantHealth and Human S · Phase I · Developing an Unbiased Machine Learning Tool for Prediction of Acute Coronary Syndrome$257K
- Federal contractHealth and Human S · Dascena R&d Effort For Coviage: Rapid Deployment Of An Accessible Machine Learning Software For COVID-19 Severity Predictions Will Progress In Work Segments With Key Deliverables Being Due During The Base Period Of Performance Of The Contract.$172K
- Federal grantNSF · Phase I · SBIR Phase I Machine Learning for Screening Acute Respiratory Distress Syndrome in General and COVID-19 Patient Populations$225K
- Federal grantHealth and Human S · Phase I · Early Identification of Acute Kidney Injury Using Deep Recurrent Neural Nets, Presented with Probable Etiology$349K
- Federal grantHealth and Human S · Phase I · Pediatric sepsis prediction: a machine learning solution for patient diversity$300K
- Federal grantHealth and Human S · Phase I · Using clinical treatment data in a machine learning approach for sepsis detection$325K
Show 4 earlier federal awards
- Federal grantHealth and Human S · Phase I · A computational approach to early sepsis detection$311K
- Federal grantHealth and Human S · Phase I · Autonomous system supporting patient specific transfer and discharge decisions$348K
- Federal grantHealth and Human S · Phase I · Autonomous system supporting patient-specific transfer and discharge decisions$348K
- Federal grantNSF · Phase I · STTR Phase I: An integrated platform for the analysis of patient health record data to enable predictive clinical decision support$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 32 peers
Line = medianDigital health · Software
- Federal grants#12 · top 38%
- Linked publications#1 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 13- PendingSystems And Methods For Automatically Notifying A Caregiver That A Patient Requires Medical InterventionUSPTOApplication 17022951
- PendingSystems And Methods For Automatically Identifying A Candidate Patient For Enrollment In A Clinical TrialUSPTOApplication 17022986
- PendingDrug Administration TimingUSPTOApplication 15934985
Show all 13 patent records
- Systems And Methods For Automatically Notifying A Caregiver That A Patient Requires Medical InterventionMar 17, 2022 · Application 17022951Pending
- Systems And Methods For Automatically Identifying A Candidate Patient For Enrollment In A Clinical TrialMar 17, 2022 · Application 17022986Pending
- Drug Administration TimingSep 26, 2019 · Application 15934985Pending
- Patient Filtering Based On Likelihood Of Side EffectsSep 26, 2019 · Application 15934986Pending
- Patient Selection Based On Drug MechanismSep 26, 2019 · Application 15934988Pending
- Diagnostic Support Systems Using Machine Learning TechniquesDec 15, 2016 · Application 14740250Pending
- Diagnostic Support Systems Using Machine Learning TechniquesDec 15, 2016 · Application 14740255Pending
- Diagnostic Support Systems Using Machine Learning TechniquesDec 15, 2016 · Application 14740254Pending
- Multi Time- Scale,multi-parameter, Differentially Weighted And Exogenous-ompensated Phylologicmeasurement AnalysesDec 15, 2016 · Application 14740259Pending
- Expansion And Contraction Around Physiological Time-Series Trajectory For Current And Future Patient Condition DeterminationDec 15, 2016 · Application 14953110Pending
- Systems And Methods For Automatically Identifying A Candidate Patient For Enrollment In A Clinical TrialApplication PCTUS2021050620Pending
- Diagnostic System For Current And Future Patient Condition DeterminationApplication PCTUS2016063000Pending
- Systems And Methods For Automatically Notifying A Caregiver That A Patient Requires Medical InterventionApplication PCTUS2021050618Pending
Recent research by its founders
- Application-driven pedagogical knowledge optimization of open-source LLMs via reinforcement learning and supervised fine-tuning20260 cites
- Generative intelligence explores the chemical space of ten million catalysts20260 cites
- Health-related Quality of Life Among Patients With Type 2 Diabetes Mellitus, Hypertension and both: A cross sectional study in a Tertiary Healthcare Centre, Kolkata.20260 cites
Related companies, and why
- DascenaShares a founder: RITANKAR DAS
- STORYUP, INC.Similar federal contract value in Digital health · $267K in contracts
- Radialogica LLCSimilar federal contract value in Digital health · $254K in contracts
- Sober Grid, Inc.Similar federal contract value in Digital health · $225K in contracts
- Life Image Inc.Similar federal contract value in Digital health · $171K in contracts
- GENVAULT CorpSimilar federal contract value in Digital health · $154K in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .